Arrowhead Research | ARWR - Attività Correnti





Attività Correnti Cambiamento Data
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
Anika Therapeutics USD 99.19M 5.63M 2026-06
Arrowhead Research USD 1.67B 168.34M 2026-06
Heron Therapeutics USD 229.84M 861K 2026-06
Incyte USD 6.03B 542.31M 2026-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Ligand Pharmaceuticals USD 1.46B 591.7M 2026-06
Merck USD 36.68B 1.66B 2026-06
Moderna USD 5.82B 45M 2026-06
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Novartis USD 27.35B 744M 2026-06
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
TG Therapeutics USD 1.15B 58.72M 2026-06
Ultragenyx Pharmaceutical USD 606M 51M 2026-06
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06
Xencor USD 523.21M 40.36M 2026-06